Project Grant R01NS142308
- Federal Grant Award Summary Baylor College of Medicine received a $632,776 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through April 30, 2030. This award funds fundamental neuroscience research investigating astrocyte voltage dynamics in the mouse visual cortex using genetically encoded voltage indicators (GEVIs). The...
- Federal Project Grant Award Summary Baylor College of Medicine received a $621,065 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) effective August 1, 2025, through July 31, 2030. The award supports the development of advanced genetically encoded voltage indicators (GEVIs) optimized for two-photon resonant scanning microscopy applications....
- Federal Project Grant Summary Baylor College of Medicine received a $246,562 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective July 3, 2025, with a completion date of September 2, 2027. The award funds research conducted in Houston, Texas, investigating the role of the germline DAAM2 (Dishevelled Associated Activator of Morphogenesis 2)...
- Federal Grant Award Summary Baylor College of Medicine received a $246,562 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 13, 2025, with completion targeted for October 12, 2027. The award supports investigator-initiated research examining causal inference in bimanual tactile processing—specifically, how the brain determines...
- Federal Grant Award Summary Baylor College of Medicine received a $400,000 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded June 26, 2025, with completion targeted for March 31, 2030. The award supports research investigating spreading depolarization (SD)—a wave of massive cellular depolarization that propagates across brain tissue—and its...
- Federal Grant Award Summary Baylor College of Medicine received a $508,533 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective February 11, 2026 through November 30, 2030. The award supports basic neuroscience research investigating state-dependent modulation of cerebellar function, specifically examining how variations in brain state...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a Project Grant of $131,360 to the University of New Haven, Incorporated, effective September 1, 2025, through August 31, 2029, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). This research initiative focuses on characterizing glioblastoma stem cell (GSC)-associated long noncoding RNA (lncRNA) GIHCG as a potential therapeutic target...
- Federal Grant Award Summary Baylor College of Medicine received a $246,562 Project Grant from the National Institute of Neurological Disorders and Stroke under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded June 16, 2025, with completion targeted for December 15, 2026. This award supports research to elucidate the disease mechanisms and develop genetic therapies for pathogenic STXBP1 (syntaxin-binding protein 1) variants, which...
- Federal Project Grant Award Summary Baylor College of Medicine received a $370,462 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), with an award date of June 3, 2025, and completion date of May 31, 2027. This grant supports the development of technical capabilities and research infrastructure to enable comparative neuroscience studies of...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $599,005 project grant to the University of Miami's Office of Research Administration on August 21, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The research will be conducted in Florida and is scheduled for completion by July 31, 2030. This award supports investigator-initiated basic and translational research...
Baylor College of Medicine received a $624,825 Project Grant award from the National Institute of Neurological Disorders and Stroke under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective March 15, 2026, with a completion date of February 28, 2031. The award supports research focused on developing computational methods to characterize the electrophysiological and genomic profiles of gliomas, specifically addressing the knowledge gap regarding how electrophysiological properties of tumor cells contribute to glioma progression and patient outcomes. The primary deliverables include the development of computational methodologies to integrate multi-modal data and systematically link molecular and electrophysiological states of glioma cells. The research utilizes patch-sequencing (patch-seq) technology, which couples electrophysiological recordings, morphological analysis, and single-cell RNA-sequencing (scRNA-seq) to characterize distinct tumor cell subtypes. These computational tools and analytical frameworks are designed to advance understanding of the mechanisms underlying electrophysiological function in both IDH (isocitrate dehydrogenase) mutant and wild-type glioma subtypes, ultimately contributing to improved prognostic and therapeutic strategies for these malignant brain tumors.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $624.8k | 3/11/26 |